Results 151 to 160 of about 21,696 (215)

Treatment With Ruxolitinib and TAK-779 Enhances GII.17 Human Norovirus Replication and Enables Serial Passaging in Human Intestinal Enteroids. [PDF]

Genes Cells
Hiraishi E, Hayashi T, Fujii Y, Kimura H, Murakami K.   +4 more
europepmc   +1 more source

Large‐scale meta‐analysis of infection risk with JAK–STAT inhibitors in 29,000 patients

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1662-1674, October 2026.
In this large meta‐analysis of 74 randomized controlled trials involving more than 29,000 patients, JAK–STAT inhibitors were associated with an increased risk of influenza, bronchitis and herpes infections, particularly herpes zoster, while an increased risk of serious opportunistic or fungal infections was not observed.
Máté Krebs, Lili Gulyás, Karen Krisztina Fazekas, Benedek Nagy, Mária Veronika Kolonics, Fanni Adél Meznerics, Norbert Kiss, András Bánvölgyi, Péter Hegyi, Péter Holló, Lajos Vince Kemény   +10 more
wiley   +1 more source

Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study. [PDF]

JAAD Int
Kent JA, Malave GS, Sacknovitz Y, Geskin LJ.   +3 more
europepmc   +1 more source

Ruxolitinib for rheumatic disease-associated macrophage activation syndrome in children: a retrospective cohort study. [PDF]

Front Immunol
Zhu X, Zhang M, Yang J, He T.
europepmc   +1 more source

Shuffling the JAKs: playing a new card in chronic GVHD. [PDF]

Blood Adv
Boiko JR, Carpenter PA.
europepmc   +1 more source

Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy. [PDF]

Hematol Oncol
Zhang Y, Zhou H, Zhang Q, Liu Q, Gao S, Xiao Z, Duan M, Ma L, Wang W, Dang H, He G, Jing H, Li J, Yang H, Zhu H, Chang C, Chen Y, Du X, Hong M, Li X, Wang J, Xu N, Suo S, Jin J.   +23 more
europepmc   +1 more source

Perioperative Management of Ruxolitinib in Primary Myelofibrosis During Coronary Artery Bypass Graft Surgery. [PDF]

Interdiscip Cardiovasc Thorac Surg
Kay M, Yates M, O'Donovan E, Tully L.
europepmc   +1 more source

Refractory Hypereosinophilic Syndrome With Clonal T-Cell Receptor Rearrangement Treated With JAK Inhibition Following Incomplete Response to IL-5 Blockade. [PDF]

Case Rep Hematol
McKaughan KW, Truong PV, Bongers G.
europepmc   +1 more source

Sequential High-Dose Ruxolitinib and Low-Dose Splenic Irradiation for Pretransplant Management of Splenomegaly Before Allogeneic Hematopoietic Cell Transplantation With Fludarabine/Busulfan-Based Conditioning in Myelofibrosis. [PDF]

EJHaem
Ke P, Feng C, Li G, Chen X, Cao Y, Hu L, Zhang J, Wang L, Zhou J.   +8 more
europepmc   +1 more source

Oral lichenoid lesions in CTLA‐4 haploinsufficiency: Targeting IFN‐γ‐driven mucosal immunopathology

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page e864-e867, October 2026.
Chen Wang, Laurie Brenchley, Teresa Greenwell‐Wild, Vasileios Ionas Theofilou, Timothy G. Myers, Chi A. Ma, Katherine Howe, Stefania Pittaluga, Steven M. Holland, Niki M. Moutsopoulos, David Fraser, Gulbu Uzel   +11 more
wiley   +1 more source